The recognition that asthma has a large inflammatory component has led to the use of steroids in its treatment. The adverse systemic effects of the drugs have promoted the development of inhaled steroids with a high topical to systemic potency ratio. The 2 most widely used agents are beclomethasone dipropionate and budesonide. Budesonide has a longer plasma elimination half-life than beclomethasone dipropionate but a higher topical to systemic potency ratio. These agents have been shown to be equipotent with respect to their anti-asthma effects but budesonide may have a slightly more favourable adverse effect profile. At low dosages (up to 400 micrograms/day) these drugs are well tolerated. At higher dosages (> 1000 micrograms/day) adverse ...
The differences in the pharmacokinetic (PK) characteristics of inhaled corticosteroids (ICSs) critic...
In both children and adults with persistent asthma, treatment with an inhaled corticosteroid (ICS) i...
The differences in the pharmacokinetic (PK) characteristics of inhaled corticosteroids (ICSs) critic...
SummaryInhaled corticosteroids form the cornerstone of treatment for most patients with asthma. A ra...
AbstractThere are significant differences in the pharmacokinetic properties of inhaled corticosteroi...
Asthma guidelines recommend the use of inhaled glucocorticoids (GCS). However, high doses increase t...
Successful management of asthmatic patients depends on achieving adequate delivery of inhaled drugs ...
SummaryThe use of systemic corticosteroids, together with bronchodilators and oxygen therapy, has be...
Inhaled corticosteroids are effective for the treatment of asthma. Because of the appreciation of th...
AbstractThe physicochemical and pharmacokinetic characteristics of BDP and budesonide are somewhat d...
ABSTRACT: The pharmacokinetic and pharmacodynamic effects of inhaled corticosteroids (ICS) have shap...
AbstractThe importance of early initiation of inhaled steroids even in mild asthma has been document...
AbstractMetered dose inhalers (MDIs) are the mainstay of inhaled steroid therapy for asthma. With th...
Inhaled corticosteroids, such as fluticasone propionate (FP) and ciclesonide (CIC), are commonly use...
AbstractThe development of inhaled agonists selective for β2-adrenoceptors and high potency corticos...
The differences in the pharmacokinetic (PK) characteristics of inhaled corticosteroids (ICSs) critic...
In both children and adults with persistent asthma, treatment with an inhaled corticosteroid (ICS) i...
The differences in the pharmacokinetic (PK) characteristics of inhaled corticosteroids (ICSs) critic...
SummaryInhaled corticosteroids form the cornerstone of treatment for most patients with asthma. A ra...
AbstractThere are significant differences in the pharmacokinetic properties of inhaled corticosteroi...
Asthma guidelines recommend the use of inhaled glucocorticoids (GCS). However, high doses increase t...
Successful management of asthmatic patients depends on achieving adequate delivery of inhaled drugs ...
SummaryThe use of systemic corticosteroids, together with bronchodilators and oxygen therapy, has be...
Inhaled corticosteroids are effective for the treatment of asthma. Because of the appreciation of th...
AbstractThe physicochemical and pharmacokinetic characteristics of BDP and budesonide are somewhat d...
ABSTRACT: The pharmacokinetic and pharmacodynamic effects of inhaled corticosteroids (ICS) have shap...
AbstractThe importance of early initiation of inhaled steroids even in mild asthma has been document...
AbstractMetered dose inhalers (MDIs) are the mainstay of inhaled steroid therapy for asthma. With th...
Inhaled corticosteroids, such as fluticasone propionate (FP) and ciclesonide (CIC), are commonly use...
AbstractThe development of inhaled agonists selective for β2-adrenoceptors and high potency corticos...
The differences in the pharmacokinetic (PK) characteristics of inhaled corticosteroids (ICSs) critic...
In both children and adults with persistent asthma, treatment with an inhaled corticosteroid (ICS) i...
The differences in the pharmacokinetic (PK) characteristics of inhaled corticosteroids (ICSs) critic...